Anuh Pharma Ltd - Stock Valuation and Financial Performance

BSE: 506260 | NSE: | Pharmaceuticals & Drugs | Small Cap

Anuh Pharma Share Price

247 -2.30 -0.92%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Anuh Pharma

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Anuh Pharma stock performance -

mw4me loader
P/E Ratio (SA):
22.66
Market Cap:
1,230.8 Cr.
52-wk low:
78.1
52-wk high:
259.7

Is Anuh Pharma Ltd an attractive stock to invest in?

1. Is Anuh Pharma Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Anuh Pharma Ltd is a good quality company.

2. Is Anuh Pharma Ltd undervalued or overvalued?

The key valuation ratios of Anuh Pharma Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Anuh Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Anuh Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Anuh Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Anuh Pharma Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 24.7%24.6%25.3%15.2%10.7%16%10.3%12.1%15.1%16.3%-
Value Creation
Index
0.80.80.80.1-0.20.1-0.3-0.10.10.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 266284326206238321307432487527640
Sales YoY Gr.-6.5%15%-36.8%15.5%34.7%-4.3%40.7%12.7%8.4%-
Adj EPS 3.84.55.53.93.153.74.76.17.410.8
YoY Gr.-16.8%22.9%-29.4%-20.7%64.2%-27%26.9%31.3%20.1%-
BVPS (₹) 17.120.123.828.129.932.932.43842.748.155.1
Adj Net
Profit
19.222.327.519.415.425.318.523.430.736.954
Cash Flow from Ops. 14.618.816.526.11.87.148.9-18.728.953.9-
Debt/CF from Ops. 000.101.30.60.9-0.70.10-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.9%17.3%19.8%8.4%
Adj EPS 7.6%19.1%26%20.1%
BVPS12.2%10%14.1%12.9%
Share Price 27% 29.6% 39.3% 211%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
23.723.92514.910.616.111.313.315.216.221
Op. Profit
Mgn %
10.511.912.3118.610.81010.510.110.211
Net Profit
Mgn %
7.27.98.49.46.57.965.46.378.5
Debt to
Equity
0000000.30.100-
Working Cap
Days
12712711617615313916915316216688
Cash Conv.
Cycle
2629335862544732504845

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 21.00%

Sales growth is growing at healthy rate in last 3 years 19.78%

Net Profit is growing at healthy rate in last 3 years 25.99%

Sales growth is good in last 4 quarters at 28.68%

No data to display

Latest Financials - Anuh Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 10.8 -
TTM Sales (₹ Cr.) 640 -
BVPS (₹.) 55.1 -
Reserves (₹ Cr.) 251 -
P/BV 4.46 -
PE 22.66 -
From the Market
52 Week Low / High (₹) 78.05 / 259.70
All Time Low / High (₹) 0.03 / 259.70
Market Cap (₹ Cr.) 1,231
Equity (₹ Cr.) 25.1
Face Value (₹) 5
Industry PE 48.2

Management X-Ray of Anuh Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Anuh Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales266284326206238321307432487527
Operating Expenses 242253289183220291284387439476
Manufacturing Costs11141816162021252735
Material Costs213220247149180241229328375399
Employee Cost 567791013141517
Other Costs 13121711151921202125
Operating Profit 24313823183023454752
Operating Profit Margin (%) 9.1%10.9%11.5%11.0%7.7%9.3%7.6%10.4%9.8%9.8%
Other Income 45487541156
Interest 1111011221
Depreciation 2322227151210
Exceptional Items 0000000000
Profit Before Tax 25323828233219393947
Tax 81012879510911
Profit After Tax 18222620172314283136
PAT Margin (%) 6.6%7.8%7.9%9.7%6.9%7.3%4.7%6.6%6.3%6.9%
Adjusted EPS (₹)3.54.45.24.03.34.72.95.76.17.2
Dividend Payout Ratio (%)37%27%24%31%42%29%48%26%29%28%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 86101119141150165162191214241
Share Capital 441313131313252525
Reserves 8297107128137152150166189216
Minority Interest0000000000
Debt002024451430
Long Term Debt0000000000
Short Term Debt002024451430
Trade Payables604852425259105120122153
Others Liabilities 1719185411158910
Total Liabilities 163168191187208239326333347404

Fixed Assets

Gross Block2423331920279698100100
Accumulated Depreciation12131524512273847
Net Fixed Assets1291817172184716153
CWIP 00006340000
Investments 27434370663980314391
Inventories19162430324361818073
Trade Receivables75687557717581107136171
Cash Equivalents 1514136811320167
Others Assets151618781718211110
Total Assets 163168191187208239326333347404

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 151916262749-192954
PBT 25323828233219393947
Adjustment -2-1-1-5-2-28784
Changes in Working Capital -3-1-811-13-1327-55-916
Tax Paid -6-11-13-8-7-10-5-10-9-13
Cash Flow From Investing Activity -5-12-5-2023-7752-8-43
Capex -1-1-11-1-7-29-36-6-1-1
Net Investments -6-133-23629-4356-9-44
Others 2234333222
Cash Flow From Financing Activity -8-8-9-4-5-722-33-19-12
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 000000-1-2-10
Dividend Paid -7-8-11-2-8-8-170-8-9
Others -102-22239-32-11-3
Net Cash Flow 2-122-13-502-2
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)21.7823.5523.4415.4311.3814.878.7516.1215.1115.9
ROCE (%)32.9435.1334.9121.6116.3120.5610.8719.7519.3321.05
Asset Turnover Ratio1.91.821.91.151.231.441.121.341.441.41
PAT to CFO Conversion(x)0.830.860.621.30.120.33.5-0.680.941.5
Working Capital Days
Receivable Days8387761109682897890106
Inventory Days28222145464260596053
Payable Days9290741159684131125117125

Anuh Pharma Ltd Stock News

Anuh Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Anuh Pharma on 28-Mar-2024 16:01 is ₹247.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Anuh Pharma stood at ₹1,230.8.
The latest P/E ratio of Anuh Pharma as of 28-Mar-2024 16:01 is 22.66.
The latest P/B ratio of Anuh Pharma as of 28-Mar-2024 16:01 is 4.46.
The 52-week high of Anuh Pharma is ₹259.7 and the 52-week low is ₹78.05.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Anuh Pharma is ₹640.4 ( Cr.) .

About Anuh Pharma Ltd

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506

Products

  • Macrolides
  • Higher Macrolides
  • Quinolones
  • Chloramphenicol
  • Anti TB Drug
  • Corticosteroids

Recognitions/Certifications

  • Anuh Pharma has received ‘Star Export House’ certification from the Ministry of Commerce and Industry.
  • The company received WHO-GMP certificate for carrying good manufacturing practices.
  • Anuh Pharma has received  ISO 9001:2000 certification
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.